Stay updated on Psilocybin Safety & Efficacy in BP-II Depression Clinical Trial
Sign up to get notified when there's something new on the Psilocybin Safety & Efficacy in BP-II Depression Clinical Trial page.

Latest updates to the Psilocybin Safety & Efficacy in BP-II Depression Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThis page history shows a new revision entry v3.4.2 added and a previous revision v3.4.1 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedRevision: v3.4.1 was added and Revision: v3.4.0 was removed from the record history.SummaryDifference0.1%

- Check27 days agoChange DetectedUI updates include showing the glossary, color-coded changes in the history (green for additions and red for deletions), and a new Revision: v3.4.0 label.SummaryDifference1%

- Check42 days agoChange DetectedRevision entry v3.3.4 was added to the history, and revision v3.3.3 was removed.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision: v3.3.3 was added. HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.SummaryDifference0.2%

- Check92 days agoChange DetectedA new revision entry v3.3.2 was added to the Record History, and the previous revision v3.2.0 was removed.SummaryDifference0.1%

Stay in the know with updates to Psilocybin Safety & Efficacy in BP-II Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Psilocybin Safety & Efficacy in BP-II Depression Clinical Trial page.